| Paper | |
|---|---|
| (NAVIGATE ESUS) Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source _____ Multicenter RCT comparing rivaroxaban to aspirin for stroke prevention in ESUS patients. The trial was terminated early due to lack of benefit of rivaroxaban for stroke prevention, and the increased rate of major bleeding. | LINK |
| (RE-SPECT ESUS) Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source _____ Multicenter RCT comparing dabigatran to aspirin for stroke prevention in ESUS patients. There was no significant difference in recurrent ischemic stroke or major bleeding between groups. | LINK |